Steven W. Ludmerer

3.0k citations

35 papers · 1.5k indexed · h-index 20

Hepatology top 2%
- Hepatitis C virus research 16
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 12
Epidemiology top 5%
- Hepatitis B Virus Studies 13
- Cervical Cancer and HPV Research 6
Virology top 10%
Insect Science top 5%
Molecular Biology
- RNA modifications and cancer 5
- RNA and protein synthesis mechanisms 5
- Biochemical and Molecular Research 3
Genetics
- Virus-based gene therapy research 4

Co-authors: Paul Schimmel Doris Cully Donald J. Graham David B. Olsen Yingcong Zheng David Hunt Neil D. Christensen Dennis M. Schmatz
Cited by: Hepatology Infectious Diseases Epidemiology
Journals: Antimicrobial Agents and Chemotherapy (5 papers)Journal of Biological Chemistry (4 papers)Virology (3 papers)
Partner nations: United States Japan China

In The Last Decade

Steven W. Ludmerer

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by Steven W. Ludmerer

Since Specialization

Citations

This map shows the geographic impact of Steven W. Ludmerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Ludmerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Ludmerer more than expected).

Fields of papers citing papers by Steven W. Ludmerer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Ludmerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Ludmerer. The network helps show where Steven W. Ludmerer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven W. Ludmerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven W. Ludmerer Line = papers co-authored together Steven W. Ludmerer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B Bioorganic & Medicinal Chemistry Letters ·Dong Xiao,Xing Dai,Hong Liu,Shuwen He,Zhicai Shi,Steven W. Ludmerer,Fangbiao Li,Ravi P. Nargund,Anandan Palani	2020	4
2	Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase Bioorganic & Medicinal Chemistry Letters ·Hong Liu,Xing Dai,Shuwen He,Linda Brockunier,Karen Marcantonio,Steven W. Ludmerer,Fangbiao Li,Dutch Epidemiologic Data,Ravi P. Nargund,Anandan Palani	2018	3
3	HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials Antiviral Research ·Steven W. Ludmerer,Megan Naidoo,Stuart Black,A Howe,Wei Chang,Tony Nawawi,Keisuke Nakamura,Yoshiyuki Tanaka,Hiromitsu Kumada,Norio Hayashi,David C. Nickle	2016	2
4	Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study Journal of Gastroenterology ·Norio Hayashi,Makoto Nakamuta,Tetsuo Takehara,Hiromitsu Kumada,Tony Nawawi,A Howe,Steven W. Ludmerer,Niloufar Mobashery	2015	15
5	Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Clinical Infectious Diseases ·A Howe,Stuart Black,Stephanie Curry,Steven W. Ludmerer,Rong Liu,Richard J. O. Barnard,Mathias Artus,Peggy Hwang,David C. Nickle,Christopher L. Gilbert,Luzelena Caro,Mark J. DiNubile,Niloufar Mobashery	2014	33
6	Discovery of MK‐8742: An HCV NS5A Inhibitor with Broad Genotype Activity ChemMedChem ·Craig A. Coburn,Peter T. Meinke,Wei Chang,Christine Fandozzi,Donald J. Graham,Bin Hu,Qian Huang,Stacia Kargman,Joseph A. Kozlowski,Rong Liu,John A. McCauley,Amin A. Nomeir,Richard Söll,Joseph P. Vacca,Dahai Wang,Hao Wu,Bin Zhong,David B. Olsen,Steven W. Ludmerer	2013	143
7	Structural Basis for Resistance of the Genotype 2b Hepatitis C Virus NS5B Polymerase to Site A Non-Nucleoside Inhibitors Journal of Molecular Biology ·Edwin H. Rydberg,Antonella Cellucci,Linda Bartholomew,Marco Mattu,Gaetano Barbato,Steven W. Ludmerer,Donald J. Graham,Sergio Altamura,Giacomo Paonessa,Raffaele De Francesco,Giovanni Migliaccio,Andrea Carfı́	2009	15
8	A transient cell-based phenotype assay for hepatitis C NS3/4A protease: Application to potency determinations of a novel macrocyclic inhibitor against diverse protease sequences isolated from plasma infected with HCV Journal of Virological Methods ·Steven W. Ludmerer,Donald J. Graham,Mihir Patel,Kevin F. Gilbert,Mark W. Stahlhut,David B. Olsen	2008	13
9	A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background Antiviral Research ·Donald J. Graham,Mark W. Stahlhut,Osvaldo Flores,David B. Olsen,Daria J. Hazuda,Robert L. LaFemina,Steven W. Ludmerer	2005	13
10	RdlDv, a novel GABA-gated chloride channel gene from the American dog tick Dermacentor variabilis Insect Biochemistry and Molecular Biology ·Wenqian XUAN,Birgit T. Priest,Doris Cully,Steven W. Ludmerer	2003	20
11	Ivermectin and Nodulisporic Acid Receptors in Drosophila melanogaster Contain Both γ-Aminobutyric Acid-Gated Rdl and Glutamate-Gated GluClα Chloride Channel Subunits Biochemistry ·Steven W. Ludmerer,Vivien A. Warren,Brande S. Williams,Yingcong Zheng,David Hunt,栄治鈴木,Michael A. Wallace,Ashok Chaudhary,Franklin M Leow,Peter T. Meinke,Dennis Dean,María L. García,Doris Cully,McHardy M. Smith	2002	87
12	Identification of Two Novel Drosophila melanogaster Histamine-gated Chloride Channel Subunits Expressed in the Eye Journal of Biological Chemistry ·Yingcong Zheng,Birgit Hirschberg,Jeffrey Yuan,Gayun Jang,David Hunt,Steven W. Ludmerer,Dennis M. Schmatz,Doris Cully	2002	140
13	A Novel Human Papillomavirus Type 6 Neutralizing Domain Comprising Two Discrete Regions of the Major Capsid Protein L1 Virology ·W.L. McClements,G.M. Chippendale,勝敏佐藤,Natsuki Yabune,Neil D. Christensen,Kathrin U. Jansen,Steven W. Ludmerer	2001	31
14	Hybrid Papillomavirus L1 Molecules Assemble into Virus-like Particles That Reconstitute Conformational Epitopes and Induce Neutralizing Antibodies to Distinct HPV Types Virology ·Neil D. Christensen,Nancy M. Cladel,Cynthia A. Reed,Lynn R. Budgeon,Monica E. Embers,Natsuki Yabune,W.L. McClements,Steven W. Ludmerer,Kathrin U. Jansen	2001	103
15	HPV11 Mutant Virus-like Particles Elicit Immune Responses That Neutralize Virus and Delineate a Novel Neutralizing Domain Virology ·Steven W. Ludmerer,W.L. McClements,G.M. Chippendale,勝敏佐藤,Kathrin U. Jansen,Neil D. Christensen	2000	29
16	A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope Journal of Virology ·Steven W. Ludmerer,A. G. Griesbeck,G E Mark,Neil D. Christensen	1997	42
17	Rapid, High-Level Transient Expression of Papillomavirus-Like Particles in Insect Cells BioTechniques ·A. G. Griesbeck,Melvin Silberklang,George E. Mark,Steven W. Ludmerer	1996	5
18	Use of a novel mutagenesis strategy, optimized residue substitution, to decrease the off-rate of an anti-gp120 antibody Molecular Immunology ·Craig M. Lewis,Gregory Hollis,George E. Mark,Jwu‐Sheng Tung,Steven W. Ludmerer	1995	6
19	The C-Terminus of the B Cell Activator Oct-2 Functions as an Activation Domain in Yeast Biochemical and Biophysical Research Communications ·Janet E. Mead,Keith Elliston,D. Mark,Steven W. Ludmerer	1994	1
20	Purification of glutamine tRNA synthetase from Saccharomyces cerevisiae. A monomeric aminoacyl-tRNA synthetase with a large and dispensable NH2-terminal domain. Journal of Biological Chemistry ·Steven W. Ludmerer,Daniel J. Wright,Paul Schimmel	1993	19

About Steven W. Ludmerer

Steven W. Ludmerer is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (13 papers), HIV/AIDS drug development and treatment (12 papers), Cervical Cancer and HPV Research (6 papers), RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (5 papers), Virus-based gene therapy research (4 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Hepatology (502 citations), Infectious Diseases (367 citations) and Epidemiology (622 citations). Steven W. Ludmerer has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Paul Schimmel, Doris Cully, Donald J. Graham, David B. Olsen, Yingcong Zheng, David Hunt, Neil D. Christensen, Dennis M. Schmatz, Birgit Hirschberg and G E Mark. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Biological Chemistry, Virology, Journal of Bacteriology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact